Prognostic factors influencing survival rates in children following lung transplantation.
OBJECTIVE
To assess the results of lung transplantation (LT) in children under 17 years of age and identify factors affecting long-term survival.


METHODS
A retrospective review was performed of 37 patients (<17 years) who had received a lung transplant between 1996 and 2007. Morbidity, mortality, and survival were analyzed by the Kaplan-Meier method and the log-rank test.


RESULTS
There were 37 LTs: 30 bilateral, four lobar, two liver-lung, one unilateral. Indications for transplantation were: cystic fibrosis (n = 30), pulmonary fibrosis (n = 1), bronchiectasis (n = 1), Kartagener's syndrome (n = 1), bronchiolitis obliterans (n = 3), and pulmonary fibrosis due to radiotherapy-chemotherapy (n = 1). The intubation time and oxygenation index of donors were 49 +/- 36 hours and 455 +/- 83.5 mm Hg, respectively. Seventeen patients needed extracorporeal circulation (ECC) and 13 were coded as priorities. High blood pressure and renal failure were the most frequent complications. Overall survival rates were 65.7%, 59.4%, 56.1%, 44.5%, and 39.6% at 1, 2, 3, 5, and 10 years, respectively. Need for ECC (P = .001), surgical complications (P = .037), oxygenation index <450 mm Hg (P = .005), OLT in priority code (P = .04), and age of donor >16 years (P = .005) were associated with poor survival.


CONCLUSIONS
LT is an appropriate procedure for certain types of end-stage pediatric pulmonary pathologies, achieving acceptable long-term survival rates. When the procedure is carried out under a surgical priority code, it is associated with a high rate of perioperative morbidity and mortality and poorer long-term survival. Other factors that have a negative influence on survival include the need for ECC, surgical complications, an oxygenation index <450 mm Hg, and donor age >16 years.
Cano
J R
JR
Thoracic Surgery and Lung Transplantation Service, Reina Sofia University Hospital, Department of Medico-Surgical Specialities, University of Cordoba, Spain. joseravich@hotmail.com
Cerezo
F
F
Algar
F J
FJ
Alvarez
A
A
Espinosa
D
D
Moreno
P
P
Baamonde
C
C
Salvatierra
A
A
D000293:Adolescent; D001987:Bronchiectasis / Q000601:surgery; D001989:Bronchiolitis Obliterans / Q000601:surgery; D002648:Child; D003550:Cystic Fibrosis / Q000601:surgery; D005500:Follow-Up Studies; D006801:Humans; D007619:Kartagener Syndrome / Q000601:surgery; D016040:Lung Transplantation / Q000401:mortality / Q000502:physiology*; D011658:Pulmonary Fibrosis / Q000209:etiology / Q000601:surgery; D011878:Radiotherapy / Q000009:adverse effects; D012189:Retrospective Studies; D015996:Survival Rate; D017741:Survivors; D013997:Time Factors; D014019:Tissue Donors / Q000706:statistics & numerical data